🎉Congratulations to CRU nurse Helen Fong RN, MSc.A, selected among 30 nominees for the #DAISYAward from the #WFNN for her outstanding contribution to nursing. She was nominated by peers at The Neuro neurosurgery unit and CRU for her teaching and excellence in patient care.

During #MSAwarenessMonth , we highlight #MOGAD , a rare #demyelinating disease. A trial at The Neuro is evaluating whether an approved treatment for #NMOSD , a related condition, can reduce the inflammatory response in MOGAD better than the current SOC. cru.mcgill.ca/ms

💡SPOTLIGHT: Medical #research , which includes #clinicalresearch , is the invisible part of our health ecosystem that drives #innovation .
Discover this and much more on CLINICAL TRIALS QUEBEC, powered by CATALIS in partnership with the government of Quebec: clinicaltrialsquebec.com/importance-cli…

On #ClinicalTrialsDay , we celebrate our amazing team of #clinicalresearch coordinators: highly trained professionals who coordinate all aspects of study visits for 100+ trials. They'll tell you that working with our inspiring participants is the best part of the job. #icdt2024

4th patient in the world to receive potential new #genetherapy treatment for #FTD with #GRN mutation was at The Neuro this month. Dr Simon Ducharme discussed the procedure on CBC News. This is the 1st gene therapy for #dementia in Canada. #mcgill cbc.ca/player/play/vi…

On International #HuntingtonsDisease Day, we celebrate advances in research for this hereditary, progressive neurological disorder. 8 studies are recruiting participants in Canada for this #raredisease , including 1 at the CRU in Montreal: cru.mcgill.ca/mvtdis. #mcgill #neuro

Helen Fong (IA, MScA) a travaillé 20 ans comme infirmière clinicienne au @Neuro_MNI avant de se joindre à nous. «À l’URC, les infirmières jouent un double rôle : nous sommes à la fine pointe de la science, mais nous prenons également soin des gens.» #nationalnursingweek #mcgill

Dr. Simon Ducharme spoke to Andrew Carter CJAD yesterday about the 1st #genetherapy trial in Canada for #dementia . This landmark study for #FTD uses a viral vector to deliver a working copy of the #GRN gene to affected individuals. #theneuro
omny.fm/shows/cjad-800…

Le Neuro est maintenant un pionnier de thérapie génique pour traiter la démence. Un patient atteint de Démence Frontotemporale ( #DFT ) a reçu une copie fonctionnelle du gène #GRN hier par vecteur virale - une première au Canada.
buff.ly/4dinMkK Génome Québec Rémi Quirion

CRU co-director Dr. Massimo Pandolfo was at #AAN AM last week, where he presented a teaching course on the diagnosis and treatment of hereditary spinocerebellar #ataxias . He is a leading expert in the field, and on the Board of the #ARSACS and #FARA foundations. #AAN #neurology

Single-use plastics are a major environmental irritant in research. In honour of #EarthDay2024 , #GreenLabs The Neuro held a #sustainability panel to discuss roadblocks and brainstorm shared solutions. Alexandra Shedov from the CRU’s Lab Team was one of the invited panelists.

The Saguenay region of Quebec has the highest prevalence of #MyotonicDystrophy in the world (1 in 400). Several new #clinicaltrials on #DM1 at the CRU are testing #ASO -based therapies that, if successful, would offer the first disease modifying treatment. cru.mcgill.ca/nm

Even #research takes a short break for a once-in-a-lifetime #eclipse ! Physicians, clinicians, researchers, clinical research coordinators and even patients headed outside to (safely) view the astronomical event.
The Neuro McGill University McGill Office for Science and Society McGill Physics

La Journée Lavande 26 Mars est la journée mondiale de sensibilisation à l'épilepsie. L’épilepsie est un trouble neurologique caractérisé par un changement soudain et bref du cerveau qui se manifeste sous forme de crise. En savoir plus buff.ly/4avrMMt

Health Canada has approved #ETNA eye-tracking software to assess #MS . An ongoing observational study at the CRU is testing if it could accurately predict #EDSS score. If successful, more sensitive, real-time biomarkers would be available to clinicians. cru.mcgill.ca/ms.

Grande nouvelle! Fiers d'annoncer que l'URC a lancé son tout premier essai de #thérapiegénique pour une maladie neurologique. Cette étude de #phase1 sur la #DFT avec mutation #GRN teste une thérapie par vecteur viral à dose unique. 1er patient dépisté cette semaine! The Neuro

Gave a talk this morning at the Royal London hospital about neurogenomics and Precision Medicine in neurodegeneration. On my way back, we went by the old Royal London building where James Parkinson used to work. Thank you Alastair Noyce for the invite!

Dr. Viviane Poupon, Brain Canada's President & CEO, highlighted open science's vital role in dementia research at the CCNA-CCNV conference this morning. From a funder's perspective, she outlined ways to leverage it for faster scientific advancement. #OpenScience